Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 8.5
Key Takeaways
Risk factor
Strong & resilient to price shocks
Data is available to registered users only
Data is available to registered users only
Profitability factor
Decent dividends
Data is available to registered users only
Data is available to registered users only
About
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. The company offers shuxuetong injections, Angong Niuhuang Wan, Danxi granules, and Gastrodia Uncaria for cardiovascular and cerebrovascular disease; Guizhi Fuling pills, Buxue Shengru granules, and hemostasis and analgesia products for gynecological disease; Schicon for respiratory disease; and Jiaqi Ganzian granules, Jianwei...
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/E
Data is available to registered users only
